Historical Stock Price
GALT historical stock prices picture
Galectin Therapeutics (GALT) has the following price history information. Looking back at GALT historical stock prices for the last five trading days, on March 22, 2024, GALT opened at $2.47, traded as high as $2.48 and as low as $2.32, and closed at $2.44. Trading volume was a total of 156.00K shares. On March 25, 2024, GALT opened at $2.44, traded as high as $2.48 and as low as $2.31, and closed at $2.33. Trading volume was a total of 134.90K shares. On March 26, 2024, GALT opened at $2.36, traded as high as $2.40 and as low as $2.27, and closed at $2.37. Trading volume was a total of 75.10K shares. On March 27, 2024, GALT opened at $2.36, traded as high as $2.42 and as low as $2.31, and closed at $2.41. Trading volume was a total of 83.00K shares. On March 28, 2024, GALT opened at $2.38, traded as high as $2.43 and as low as $2.30, and closed at $2.39. Trading volume was a total of 57.70K shares.

GALT Historical Stock Prices By Date:

GALT historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Galectin Therapeutics shares, starting with a $10,000 purchase of GALT, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/01/2014
End date: 03/28/2024
Start price/share: $13.58
End price/share: $2.39
Dividends collected/share: $0.00
Total return: -82.40%
Average Annual Total Return: -15.95%
Starting investment: $10,000.00
Ending investment: $1,760.29
Years: 10.00
Date Open High Low Close Volume
03/22/2024 $2.47 $2.48 $2.32 $2.44 156.00K
03/25/2024 $2.44 $2.48 $2.31 $2.33 134.90K
03/26/2024 $2.36 $2.40 $2.27 $2.37 75.10K
03/27/2024 $2.36 $2.42 $2.31 $2.41 83.00K
03/28/2024 $2.38 $2.43 $2.30 $2.39 57.70K
Galectin Therapeutics is a clinical stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease, cancer and selected other diseases. Co.'s main galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis and in clinical studies to decrease portal hypertension and prevent its complication: the development of esophageal varices. GR-MD-02 has the potential to treat various diseases due to galectin-3's involvement in multiple main biological pathways such as fibrosis, immune cell function and immunity, cell differentiation, cell growth, and apoptosis (cell death).
Date Close
03/22/2024$2.44
03/25/2024$2.33
03/26/2024$2.37
03/27/2024$2.41
03/28/2024$2.39
GALT is categorized under the Healthcare sector; below are some other companies in the same sector:

GAP Historical Stock Prices
GB Historical Stock Prices
GBIM Historical Stock Prices
GBSN Historical Stock Prices
GBT Historical Stock Prices
GEMP Historical Stock Prices
GEN Historical Stock Prices
GENE Historical Stock Prices
GENT Historical Stock Prices
GERN Historical Stock Prices

Also explore: GALT shares outstanding history

Email EnvelopeFree GALT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


GALT Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.